NLRP3 and synovial sarcoma: Activation of NLRP3 also promotes substantial production of inflammatory cytokines IL-1β and IL-18 in peripheral blood stem mononuclear cells (PBMCs), driving chronic inflammation and tissue injury in SS (25).